Shifting from oral contraceptives to norethisterone acetate, or vice versa, because of drug intolerance: Does the change benefit women with endometriosis?
Gynecologic and Obstetric Investigation Mar 02, 2018
Vercellini P, et al. - Researchers here investigated if shifting from low-dose oral contraceptives (OC) to norethisterone acetate (NETA) (2.5 mg/day), or vice versa, improved tolerability among women with Endometriosis. They found that shifting from OC to NETA, or vice versa, because of side effects, improved tolerability in selected endometriosis patients. When substituting NETA with OC rather than the other way round, better results were observed.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
